Sponsors

Ready-to-use miRNA assays

Two ready-to-use microRNA (miRNA) assay technologies have been introduced by Qiagen. The two new products, miScript miRNA Mimics and miScript miRNA Inhibitors, are ready-totransfect items for use in gene regulation and cellular pathway analysis.

miScript miRNA Mimics are synthetic RNA oligonucleotides that function like mature endogenous miRNA molecules when transfected in mammalian cells. miScript miRNA Inhibitors are synthetic chemically modified RNA oligonucleotides that inhibit endogenously expressed miRNAs. miRNA Inhibitors effectively lower the levels of endogenous miRNA in cells, thus enabling loss-of-function studies to be performed.

Qiagen supplies miScript miRNA Mimics and miScript miRNA Inhibitors in formats from single tubes to 96- or 384-well plates, and also in different scales (1 nmol and 5 nmol for in vitro use, and 20 nmol for animal studies).

www.qiagen.com

Latest Issues

2nd Global Summit on Pathology

Rome, Italy
10-11 April, 2025

The 10 Year Plan - Clinical Innovations Expo

Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025

Transforming Digital Pathology & AI: The Path Forward

Royal College Of Physicians Of Edinburgh
15 May, 2025

BSMT 40th Anniversary Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

LabMedUK25

Bridgewater Hall, Manchester
9-11 June, 2025